表紙
市場調查報告書

動物醫療的全球市場:2020年∼2024年

Global Animal Healthcare Market 2020-2024

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 603609
出版日期 內容資訊 英文 120 Pages
訂單完成後即時交付
價格
動物醫療的全球市場:2020年∼2024年 Global Animal Healthcare Market 2020-2024
出版日期: 2020年01月30日內容資訊: 英文 120 Pages
簡介

全球動物醫療市場在2020年∼2024年的預測期間內,預計將以4%的年複合成長率增長,達到79億8,000萬美元的規模。該市場的成長主要因素有人畜共患疾病的發病率增加。此外,有機微量元素在改善畜牧生產中的作用正在增加,並有望進一步推動市場增長。

本報告提供全球動物醫療市場相關調查分析,提供市場規模及成長率,市場趨勢,推動市場要素,課題,市場機會驗證,再加上主要供應商等相關的系統性資訊。

目錄

摘要整理

  • 市場概況

市場形勢

  • 市場生態系統
  • 價值鏈分析

市場規模

  • 市場定義
  • 市場區隔分析
  • 市場規模:2019年
  • 市場預測:2019-2024年的預測

波特的五力分析

  • 波特的五力分析摘要
  • 買主談判力
  • 供應商談判力
  • 新加入廠商的威脅
  • 替代品的威脅
  • 對手的威脅
  • 市場情況

市場區隔:各產品

  • 市場區隔
  • 各產品比較:市場規模與預測2019-2024
  • 醫藥品
  • 飼料添加物
  • 生物學
  • 市場機會:各產品

客戶形勢

  • 概要

各地區形勢

  • 各地區市場區隔
  • 各地區比較
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲地區
  • 主要國家
  • 市場機會:各地區

成長要素,課題,及趨勢

  • 市場成長要素
  • 交易量的成長要素-需求主導型成長
  • 交易量的成長要素-供給主導型成長
  • 交易量的成長要素-外部要素
  • 交易量的成長要素-需求轉移到鄰近市場
  • 價格上升要素-通貨膨脹
  • 價格成長要素-從低價格單位轉變到高價格單位
  • 市場課題
  • 市場趨勢

業者情勢

  • 概要
  • 業者情勢
  • 形勢的創新

供應商分析

  • 交易廠商
  • 供應商的市場定位
  • Bayer AG
  • C. H. Boehringer Sohn AG & Co. KG
  • Cadila Healthcare Ltd.
  • Dechra Pharmaceuticals Plc
  • Elanco Animal Health Inc.
  • Heska Corp.
  • Merck & Co. Inc.
  • Norbrook Laboratories Ltd.
  • Virbac SA
  • Zoetis Inc.

附錄

  • 調查範圍
  • 美金的貨幣換算比率
  • 調查方法
  • 簡稱的清單

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR40456

Technavio has been monitoring the global animal healthcare market and it is poised to grow by USD 7.98 bn during 2020-2024, progressing at a CAGR of 4% during the forecast period. Our reports on global animal healthcare market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by rise in incidences of zoonotic diseases.In addition, increasing role of organic tracing elements for improving livestock production is anticipated to boost the growth of the global animal healthcare market as well.

Market Segmentation

Technavio's global animal healthcare market is segmented as below:

Product:

  • Pharmaceutical
  • Feed Additive
  • Biological

Geographic segmentation

  • North America
  • APAC
  • Europe
  • South America
  • MEA

Key Trends for global animal healthcare market growth

This study identifies increasing role of organic tracing elements for improving livestock production as the prime reasons driving the global animal healthcare market growth during the next few years.

Prominent vendors in global animal healthcare market

We provide a detailed analysis of around 25 vendors operating in the global animal healthcare market, including some of the vendors such as Bayer AG, C. H. Boehringer Sohn AG & Co. KG, Cadila Healthcare Ltd., Dechra Pharmaceuticals Plc, Elanco Animal Health Inc., Heska Corp., Merck & Co. Inc., Norbrook Laboratories Ltd., Virbac SA and Zoetis Inc. .

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Five Forces Summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Product

  • Market segments
  • Comparison by Product placement
  • Pharmaceutical - Market size and forecast 2019-2024
  • Feed additive - Market size and forecast 2019-2024
  • Biologicals - Market size and forecast 2019-2024
  • Market opportunity by Product

Customer landscape

  • Overview

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • APAC - Market size and forecast 2019-2024
  • South America - Market size and forecast 2019-2024
  • MEA - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography

Drivers, Challenges, and Trends

  • Market drivers
  • Volume driver - Demand led growth
  • Volume driver - Supply led growth
  • Volume driver - External factors
  • Volume driver - Demand shift in adjacent markets
  • Price driver - Inflation
  • Price driver - Shift from lower to higher-priced units
  • Market challenges
  • Market trends

Vendor Landscape

  • Overview
  • Vendor landscape
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Bayer AG
  • C. H. Boehringer Sohn AG & Co. KG
  • Cadila Healthcare Ltd.
  • Dechra Pharmaceuticals Plc
  • Elanco Animal Health Inc.
  • Heska Corp.
  • Merck & Co. Inc.
  • Norbrook Laboratories Ltd.
  • Virbac SA
  • Zoetis Inc.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

List of Exhibits:

  • 1.Key Finding 1
  • 2.Key Finding 2
  • 3.Key Finding 3
  • 4.Key Finding 4
  • 5.Key Finding 5
  • 6.Key Finding 6
  • 7.Key Finding 7
  • 8.Market in focus
  • 9.Parent market
  • 10.Market characteristics
  • 11.Product / Service portfolio of key vendors included in the market definition
  • 12.Market segments
  • 13.Global - Market size and forecast 2019 - 2024 ($ billion)
  • 14.Global market: Year-over-year growth 2019 - 2024 (%)
  • 15.Five forces analysis 2019 & 2024
  • 16.Bargaining power of buyers
  • 17.Bargaining power of suppliers
  • 18.Threat of new entrants
  • 19.Threat of substitutes
  • 20.Threat of rivalry
  • 21.Market condition - Five forces 2019
  • 22.Product placement - Market share 2019-2024 (%)
  • 23.Comparison by Product placement
  • 24.Pharmaceutical - Market size and forecast 2019-2024 ($ billion)
  • 25.Pharmaceutical - Year-over-year growth 2019-2024 (%)
  • 26.Feed additive - Market size and forecast 2019-2024 ($ billion)
  • 27.Feed additive - Year-over-year growth 2019-2024 (%)
  • 28.Biologicals - Market size and forecast 2019-2024 ($ billion)
  • 29.Biologicals - Year-over-year growth 2019-2024 (%)
  • 30. Market opportunity by Product
  • 31.Customer landscape
  • 32.Market share by geography 2019-2024 (%)
  • 33.Geographic comparison
  • 34.North America - Market size and forecast 2019-2024 ($ billion)
  • 35.North America - Year-over-year growth 2019-2024 (%)
  • 36.Europe - Market size and forecast 2019-2024 ($ billion)
  • 37.Europe - Year-over-year growth 2019-2024 (%)
  • 38.APAC - Market size and forecast 2019-2024 ($ billion)
  • 39.APAC - Year-over-year growth 2019-2024 (%)
  • 40.South America - Market size and forecast 2019-2024 ($ billion)
  • 41.South America - Year-over-year growth 2019-2024 (%)
  • 42.MEA - Market size and forecast 2019-2024 ($ billion)
  • 43.MEA - Year-over-year growth 2019-2024 (%)
  • 44.Key leading countries
  • 45.Market opportunity by geography ($ billion)
  • 46.Impact of drivers
  • 47.Impact of challenges
  • 48.Landscape disruption
  • 49.Industry risks
  • 50.Vendors covered
  • 51.Market positioning of vendors
  • 52.Bayer AG - Overview (1/3)
  • 53.Bayer AG - Overview (2/3)
  • 54.Bayer AG - Overview (3/3)
  • 55.Bayer AG - Business segments
  • 56.Bayer AG - Key offerings
  • 57.Bayer AG - Key customers
  • 58.Bayer AG - Segment focus
  • 59.C. H. Boehringer Sohn AG & Co. KG - Overview (1/3)
  • 60.C. H. Boehringer Sohn AG & Co. KG - Overview (2/3)
  • 61.C. H. Boehringer Sohn AG & Co. KG - Overview (3/3)
  • 62.C. H. Boehringer Sohn AG & Co. KG - Business segments
  • 63.C. H. Boehringer Sohn AG & Co. KG - Key offerings
  • 64.C. H. Boehringer Sohn AG & Co. KG - Key customers
  • 65.C. H. Boehringer Sohn AG & Co. KG - Segment focus
  • 66.Cadila Healthcare Ltd. - Overview (1/3)
  • 67.Cadila Healthcare Ltd. - Overview (2/3)
  • 68.Cadila Healthcare Ltd. - Overview (3/3)
  • 69.Cadila Healthcare Ltd. - Business segments
  • 70.Cadila Healthcare Ltd. - Key offerings
  • 71.Cadila Healthcare Ltd. - Key customers
  • 72.Cadila Healthcare Ltd. - Segment focus
  • 73.Dechra Pharmaceuticals Plc - Overview (1/3)
  • 74.Dechra Pharmaceuticals Plc - Overview (2/3)
  • 75.Dechra Pharmaceuticals Plc - Overview (3/3)
  • 76.Dechra Pharmaceuticals Plc - Business segments
  • 77.Dechra Pharmaceuticals Plc - Key offerings
  • 78.Dechra Pharmaceuticals Plc - Key customers
  • 79.Dechra Pharmaceuticals Plc - Segment focus
  • 80.Elanco Animal Health Inc. - Overview (1/3)
  • 81.Elanco Animal Health Inc. - Overview (2/3)
  • 82.Elanco Animal Health Inc. - Overview (3/3)
  • 83.Elanco Animal Health Inc. - Business segments
  • 84.Elanco Animal Health Inc. - Key offerings
  • 85.Elanco Animal Health Inc. - Key customers
  • 86.Elanco Animal Health Inc. - Segment focus
  • 87.Heska Corp. - Overview (1/3)
  • 88.Heska Corp. - Overview (2/3)
  • 89.Heska Corp. - Overview (3/3)
  • 90.Heska Corp. - Business segments
  • 91.Heska Corp. - Key offerings
  • 92.Heska Corp. - Key customers
  • 93.Heska Corp. - Segment focus
  • 94.Merck & Co. Inc. - Overview (1/3)
  • 95.Merck & Co. Inc. - Overview (2/3)
  • 96.Merck & Co. Inc. - Overview (3/3)
  • 97.Merck & Co. Inc. - Business segments
  • 98.Merck & Co. Inc. - Key offerings
  • 99.Merck & Co. Inc. - Key customers
  • 100.Merck & Co. Inc. - Segment focus
  • 101.Norbrook Laboratories Ltd. - Overview (1/3)
  • 102.Norbrook Laboratories Ltd. - Overview (2/3)
  • 103.Norbrook Laboratories Ltd. - Overview (3/3)
  • 104.Norbrook Laboratories Ltd. - Product and service
  • 105.Norbrook Laboratories Ltd. - Key offerings
  • 106.Norbrook Laboratories Ltd. - Key customers
  • 107.Norbrook Laboratories Ltd. - Segment focus
  • 108.Virbac SA - Overview (1/3)
  • 109.Virbac SA - Overview (2/3)
  • 110.Virbac SA - Overview (3/3)
  • 111.Virbac SA - Business segments
  • 112.Virbac SA - Key offerings
  • 113.Virbac SA - Key customers
  • 114.Virbac SA - Segment focus
  • 115.Zoetis Inc. - Overview (1/3)
  • 116.Zoetis Inc. - Overview (2/3)
  • 117.Zoetis Inc. - Overview (3/3)
  • 118.Zoetis Inc. - Business segments
  • 119.Zoetis Inc. - Key offerings
  • 120.Zoetis Inc. - Key customers
  • 121.Zoetis Inc. - Segment focus
  • 122.Currency conversion rates for US$
  • 123.Research Methodology
  • 124.Validation techniques employed for market sizing
  • 125.Information sources
  • 126.List of abbreviations